NYMOFEX
Dead / Abandoned — Abandoned — no statement of use filed (as of 13 Nov 2023)
What this means for you
This application is over — abandoned 13 Nov 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88876248
- Mark type
- Stylized text
- Filed
- 17 Apr 2020
- Published for opposition
- 18 Aug 2020
- Abandoned
- 13 Nov 2023
- Attorney of record
- Patrick J. Jennings
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of benign prostatic hyperplasia and prostate cancer
Owner
- Nymox Pharmaceutical Corporation, Nassau, BS
- Nymox Pharmaceutical Corporation, Nassau, BS
Prosecution history
- 13 Nov 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 13 Nov 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 17 Mar 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Mar 2023 — SOU EXTENSION 5 GRANTED
- 06 Mar 2023 — SOU EXTENSION 5 FILED
- 16 Mar 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 06 Mar 2023 — SOU TEAS EXTENSION RECEIVED
- 12 Oct 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Oct 2022 — SOU EXTENSION 4 GRANTED
- 10 Oct 2022 — SOU EXTENSION 4 FILED
- 10 Oct 2022 — SOU TEAS EXTENSION RECEIVED
- 26 Feb 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Feb 2022 — SOU EXTENSION 3 GRANTED
- 24 Feb 2022 — SOU EXTENSION 3 FILED
- 24 Feb 2022 — SOU TEAS EXTENSION RECEIVED